CLEVELAND, Dec. 13, 2017 -- ExactCare® Pharmacy has expanded its Executive Leadership Team, welcoming seasoned health care executive Terry Rogers to the newly created role of Chief Growth Officer (CGO). The addition of this role is the result of the company’s rapid growth and continued evolution as a strategic value-based health care partner to providers, payers, PBMs and other organizations across the health care spectrum.
As CGO, Rogers will provide strategic oversight and executive leadership for business development, sales, client relations, product development and marketing.
“This new role is significant for ExactCare because it will bring an even stronger focus on supporting the ever-changing needs of our partners in the health care industry and ensuring visibility to the outcomes we help them achieve,” said Dale Wollschleger, R.Ph., President and CEO. “Terry’s impressive career has spanned numerous functional leadership roles in the health care industry, equipping him with a level of expertise that will be invaluable to ExactCare.”
Rogers has more than 30 years’ experience in the pharmacy benefit management, specialty pharmacy and pharmaceutical manufacturer industries. His background includes 14 years of leadership positions with Express Scripts, including six years as President, Health Plan Division. In this role he held overall responsibility for strategy, profitability, sales and retention of the company’s health plan clients.
Since leaving Express Scripts, Rogers has consulted with several private equity firms, professional services organizations and middle market health care companies, as well as served on the Board of Directors of a privately held pharmacy benefit manager recently acquired by Magellan Health.
“I’m excited to join this leadership team and organization because of the value ExactCare offers its clients, their members and their patients. The company has built a unique pharmacy care management solution that has a very real impact on health, quality of life and costs of the most medically complex patients through a model that complements the efforts of health plans, PBMs, providers and home health organizations,” Rogers said. “Our proven ability to simplify and improve the challenges of drug adherence for polypharmacy patients, reduce hospital readmissions, and drive down total cost of care provides true value to all parties in the delivery of health care.”
About ExactCare
ExactCare partners with health care organizations to provide comprehensive medication management for medically complex, high-risk patients. Our approach helps patients overcome the challenges of polypharmacy while enabling health care organizations to achieve better clinical and economic outcomes. ExactCare utilizes a high-touch, long-term care pharmacy-at-home model coupled with proprietary technology and automation to provide customized care tailored to each patient’s needs.
Contact
Kara Slater, Marketing & Corporate Communications, ExactCare
[email protected]


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Washington Post Publisher Will Lewis Steps Down After Layoffs
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 



